ELOXATIN
- Product NDC
- 12516-0592
- 11-digit product format
- 125160592
- Labeler code
- 12516
- Product ID
- 12516-0592_4057b792-ee8b-46ad-a497-9691e43d362b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxaliplatin
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Aventis Pharma Ltd.
- Application
- NDA021759
- Marketing category
- NDA
- Marketing start
- 2009-07-22
- Marketing end
- 0000-00-00
- Substance
- OXALIPLATIN
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record